Global Cell and Advanced Therapies Supply Chain Management Market Size, Status and Forecast 2024-2031

Report ID: 919283 | Published Date: Jan 2025 | No. of Page: 123 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cloud
        1.2.3 On-premises
    1.3 Market by Application
        1.3.1 Global Cell and Advanced Therapies Supply Chain Management Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Biobank
        1.3.3 Cell Therapy Lab
        1.3.4 Hospital
        1.3.5 Research Institute
        1.3.6 Commercial Organization
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cell and Advanced Therapies Supply Chain Management Market Perspective (2016-2027)
    2.2 Cell and Advanced Therapies Supply Chain Management Growth Trends by Regions
        2.2.1 Cell and Advanced Therapies Supply Chain Management Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cell and Advanced Therapies Supply Chain Management Historic Market Share by Regions (2016-2021)
        2.2.3 Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Regions (2022-2027)
    2.3 Cell and Advanced Therapies Supply Chain Management Industry Dynamic
        2.3.1 Cell and Advanced Therapies Supply Chain Management Market Trends
        2.3.2 Cell and Advanced Therapies Supply Chain Management Market Drivers
        2.3.3 Cell and Advanced Therapies Supply Chain Management Market Challenges
        2.3.4 Cell and Advanced Therapies Supply Chain Management Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue
        3.1.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue (2016-2021)
        3.1.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Players (2016-2021)
    3.2 Global Cell and Advanced Therapies Supply Chain Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cell and Advanced Therapies Supply Chain Management Revenue
    3.4 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio
        3.4.1 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell and Advanced Therapies Supply Chain Management Revenue in 2020
    3.5 Cell and Advanced Therapies Supply Chain Management Key Players Head office and Area Served
    3.6 Key Players Cell and Advanced Therapies Supply Chain Management Product Solution and Service
    3.7 Date of Enter into Cell and Advanced Therapies Supply Chain Management Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Advanced Therapies Supply Chain Management Breakdown Data by Type
    4.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Type (2016-2021)
    4.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2022-2027)

5 Cell and Advanced Therapies Supply Chain Management Breakdown Data by Application
    5.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Application (2016-2021)
    5.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cell and Advanced Therapies Supply Chain Management Market Size (2016-2027)
    6.2 North America Cell and Advanced Therapies Supply Chain Management Market Size by Type
        6.2.1 North America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021)
        6.2.2 North America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027)
        6.2.3 North America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2027)
    6.3 North America Cell and Advanced Therapies Supply Chain Management Market Size by Application
        6.3.1 North America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021)
        6.3.2 North America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027)
        6.3.3 North America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2027)
    6.4 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country
        6.4.1 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021)
        6.4.2 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size (2016-2027)
    7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type
        7.2.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021)
        7.2.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027)
        7.2.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2027)
    7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application
        7.3.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021)
        7.3.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027)
        7.3.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2027)
    7.4 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country
        7.4.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021)
        7.4.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size (2016-2027)
    8.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type
        8.2.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application
        8.3.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region
        8.4.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size (2016-2027)
    9.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type
        9.2.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021)
        9.2.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027)
        9.2.3 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2027)
    9.3 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application
        9.3.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021)
        9.3.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027)
        9.3.3 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2027)
    9.4 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country
        9.4.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021)
        9.4.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size (2016-2027)
    10.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type
        10.2.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application
        10.3.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country
        10.4.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Be The Match BioTherapies
        11.1.1 Be The Match BioTherapies Company Details
        11.1.2 Be The Match BioTherapies Business Overview
        11.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Introduction
        11.1.4 Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.1.5 Be The Match BioTherapies Recent Development
    11.2 Brooks Life Sciences
        11.2.1 Brooks Life Sciences Company Details
        11.2.2 Brooks Life Sciences Business Overview
        11.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Introduction
        11.2.4 Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.2.5 Brooks Life Sciences Recent Development
    11.3 Clarkston Consulting
        11.3.1 Clarkston Consulting Company Details
        11.3.2 Clarkston Consulting Business Overview
        11.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Introduction
        11.3.4 Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.3.5 Clarkston Consulting Recent Development
    11.4 Cryoport
        11.4.1 Cryoport Company Details
        11.4.2 Cryoport Business Overview
        11.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Introduction
        11.4.4 Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.4.5 Cryoport Recent Development
    11.5 Haemonetics
        11.5.1 Haemonetics Company Details
        11.5.2 Haemonetics Business Overview
        11.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Introduction
        11.5.4 Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.5.5 Haemonetics Recent Development
    11.6 Hypertrust Patient Data Care
        11.6.1 Hypertrust Patient Data Care Company Details
        11.6.2 Hypertrust Patient Data Care Business Overview
        11.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Introduction
        11.6.4 Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.6.5 Hypertrust Patient Data Care Recent Development
    11.7 Lykan Bioscience
        11.7.1 Lykan Bioscience Company Details
        11.7.2 Lykan Bioscience Business Overview
        11.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Introduction
        11.7.4 Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.7.5 Lykan Bioscience Recent Development
    11.8 MAK-SYSTEM
        11.8.1 MAK-SYSTEM Company Details
        11.8.2 MAK-SYSTEM Business Overview
        11.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Introduction
        11.8.4 MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.8.5 MAK-SYSTEM Recent Development
    11.9 MasterControl
        11.9.1 MasterControl Company Details
        11.9.2 MasterControl Business Overview
        11.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Introduction
        11.9.4 MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.9.5 MasterControl Recent Development
    11.10 SAP
        11.10.1 SAP Company Details
        11.10.2 SAP Business Overview
        11.10.3 SAP Cell and Advanced Therapies Supply Chain Management Introduction
        11.10.4 SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.10.5 SAP Recent Development
    11.11 SAVSU Technologies
        11.11.1 SAVSU Technologies Company Details
        11.11.2 SAVSU Technologies Business Overview
        11.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Introduction
        11.11.4 SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.11.5 SAVSU Technologies Recent Development
    11.12 sedApta Group
        11.12.1 sedApta Group Company Details
        11.12.2 sedApta Group Business Overview
        11.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Introduction
        11.12.4 sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.12.5 sedApta Group Recent Development
    11.13 Stafa Cellular Therapy
        11.13.1 Stafa Cellular Therapy Company Details
        11.13.2 Stafa Cellular Therapy Business Overview
        11.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Introduction
        11.13.4 Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.13.5 Stafa Cellular Therapy Recent Development
    11.14 Title21 Health Solutions
        11.14.1 Title21 Health Solutions Company Details
        11.14.2 Title21 Health Solutions Business Overview
        11.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Introduction
        11.14.4 Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.14.5 Title21 Health Solutions Recent Development
    11.15 TraceLink
        11.15.1 TraceLink Company Details
        11.15.2 TraceLink Business Overview
        11.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Introduction
        11.15.4 TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.15.5 TraceLink Recent Development
    11.16 TrakCel
        11.16.1 TrakCel Company Details
        11.16.2 TrakCel Business Overview
        11.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Introduction
        11.16.4 TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.16.5 TrakCel Recent Development
    11.17 Vineti
        11.17.1 Vineti Company Details
        11.17.2 Vineti Business Overview
        11.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Introduction
        11.17.4 Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
        11.17.5 Vineti Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cloud
    Table 3. Key Players of On-premises
    Table 4. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Cell and Advanced Therapies Supply Chain Management Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cell and Advanced Therapies Supply Chain Management Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Cell and Advanced Therapies Supply Chain Management Market Share by Regions (2016-2021)
    Table 8. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Cell and Advanced Therapies Supply Chain Management Market Share by Regions (2022-2027)
    Table 10. Cell and Advanced Therapies Supply Chain Management Market Trends
    Table 11. Cell and Advanced Therapies Supply Chain Management Market Drivers
    Table 12. Cell and Advanced Therapies Supply Chain Management Market Challenges
    Table 13. Cell and Advanced Therapies Supply Chain Management Market Restraints
    Table 14. Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players (2016-2021)
    Table 16. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2020)
    Table 17. Ranking of Global Top Cell and Advanced Therapies Supply Chain Management Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Cell and Advanced Therapies Supply Chain Management Product Solution and Service
    Table 21. Date of Enter into Cell and Advanced Therapies Supply Chain Management Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2016-2021)
    Table 25. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Cell and Advanced Therapies Supply Chain Management Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2016-2021)
    Table 29. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Be The Match BioTherapies Company Details
    Table 62. Be The Match BioTherapies Business Overview
    Table 63. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product
    Table 64. Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 65. Be The Match BioTherapies Recent Development
    Table 66. Brooks Life Sciences Company Details
    Table 67. Brooks Life Sciences Business Overview
    Table 68. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product
    Table 69. Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 70. Brooks Life Sciences Recent Development
    Table 71. Clarkston Consulting Company Details
    Table 72. Clarkston Consulting Business Overview
    Table 73. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product
    Table 74. Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 75. Clarkston Consulting Recent Development
    Table 76. Cryoport Company Details
    Table 77. Cryoport Business Overview
    Table 78. Cryoport Cell and Advanced Therapies Supply Chain Management Product
    Table 79. Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 80. Cryoport Recent Development
    Table 81. Haemonetics Company Details
    Table 82. Haemonetics Business Overview
    Table 83. Haemonetics Cell and Advanced Therapies Supply Chain Management Product
    Table 84. Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 85. Haemonetics Recent Development
    Table 86. Hypertrust Patient Data Care Company Details
    Table 87. Hypertrust Patient Data Care Business Overview
    Table 88. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product
    Table 89. Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 90. Hypertrust Patient Data Care Recent Development
    Table 91. Lykan Bioscience Company Details
    Table 92. Lykan Bioscience Business Overview
    Table 93. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product
    Table 94. Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 95. Lykan Bioscience Recent Development
    Table 96. MAK-SYSTEM Company Details
    Table 97. MAK-SYSTEM Business Overview
    Table 98. MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 99. MAK-SYSTEM Recent Development
    Table 100. MasterControl Company Details
    Table 101. MasterControl Business Overview
    Table 102. MasterControl Cell and Advanced Therapies Supply Chain Management Product
    Table 103. MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 104. MasterControl Recent Development
    Table 105. SAP Company Details
    Table 106. SAP Business Overview
    Table 107. SAP Cell and Advanced Therapies Supply Chain Management Product
    Table 108. SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 109. SAP Recent Development
    Table 110. SAVSU Technologies Company Details
    Table 111. SAVSU Technologies Business Overview
    Table 112. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product
    Table 113. SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 114. SAVSU Technologies Recent Development
    Table 115. sedApta Group Company Details
    Table 116. sedApta Group Business Overview
    Table 117. sedApta Group Cell and Advanced Therapies Supply Chain Management Product
    Table 118. sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 119. sedApta Group Recent Development
    Table 120. Stafa Cellular Therapy Company Details
    Table 121. Stafa Cellular Therapy Business Overview
    Table 122. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product
    Table 123. Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 124. Stafa Cellular Therapy Recent Development
    Table 125. Title21 Health Solutions Company Details
    Table 126. Title21 Health Solutions Business Overview
    Table 127. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product
    Table 128. Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 129. Title21 Health Solutions Recent Development
    Table 130. TraceLink Company Details
    Table 131. TraceLink Business Overview
    Table 132. TraceLink Cell and Advanced Therapies Supply Chain Management Product
    Table 133. TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 134. TraceLink Recent Development
    Table 135. TrakCel Company Details
    Table 136. TrakCel Business Overview
    Table 137. TrakCel Cell and Advanced Therapies Supply Chain Management Product
    Table 138. TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 139. TrakCel Recent Development
    Table 140. Vineti Company Details
    Table 141. Vineti Business Overview
    Table 142. Vineti Cell and Advanced Therapies Supply Chain Management Product
    Table 143. Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2016-2021) & (US$ Million)
    Table 144. Vineti Recent Development
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell and Advanced Therapies Supply Chain Management Market Share by Type: 2020 VS 2027
    Figure 2. Cloud Features
    Figure 3. On-premises Features
    Figure 4. Global Cell and Advanced Therapies Supply Chain Management Market Share by Application: 2020 VS 2027
    Figure 5. Biobank Case Studies
    Figure 6. Cell Therapy Lab Case Studies
    Figure 7. Hospital Case Studies
    Figure 8. Research Institute Case Studies
    Figure 9. Commercial Organization Case Studies
    Figure 10. Cell and Advanced Therapies Supply Chain Management Report Years Considered
    Figure 11. Global Cell and Advanced Therapies Supply Chain Management Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Cell and Advanced Therapies Supply Chain Management Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Cell and Advanced Therapies Supply Chain Management Market Share by Regions: 2020 VS 2027
    Figure 14. Global Cell and Advanced Therapies Supply Chain Management Market Share by Regions (2022-2027)
    Figure 15. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players in 2020
    Figure 16. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue in 2020
    Figure 18. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2016-2021)
    Figure 19. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2022-2027)
    Figure 20. North America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Cell and Advanced Therapies Supply Chain Management Market Share by Type (2016-2027)
    Figure 22. North America Cell and Advanced Therapies Supply Chain Management Market Share by Application (2016-2027)
    Figure 23. North America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2016-2027)
    Figure 24. United States Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Cell and Advanced Therapies Supply Chain Management Market Share by Type (2016-2027)
    Figure 28. Europe Cell and Advanced Therapies Supply Chain Management Market Share by Application (2016-2027)
    Figure 29. Europe Cell and Advanced Therapies Supply Chain Management Market Share by Country (2016-2027)
    Figure 30. Germany Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Share by Region (2016-2027)
    Figure 40. China Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Cell and Advanced Therapies Supply Chain Management Market Share by Type (2016-2027)
    Figure 48. Latin America Cell and Advanced Therapies Supply Chain Management Market Share by Application (2016-2027)
    Figure 49. Latin America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2016-2027)
    Figure 50. Mexico Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Share by Country (2016-2027)
    Figure 56. Turkey Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Be The Match BioTherapies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 60. Brooks Life Sciences Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 61. Clarkston Consulting Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 62. Cryoport Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 63. Haemonetics Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 64. Hypertrust Patient Data Care Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 65. Lykan Bioscience Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 66. MAK-SYSTEM Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 67. MasterControl Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 68. SAP Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 69. SAVSU Technologies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 70. sedApta Group Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 71. Stafa Cellular Therapy Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 72. Title21 Health Solutions Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 73. TraceLink Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 74. TrakCel Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 75. Vineti Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Be The Match BioTherapies
Brooks Life Sciences
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
MAK-SYSTEM
MasterControl
SAP
SAVSU Technologies
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink
TrakCel
Vineti
Frequently Asked Questions
Cell and Advanced Therapies Supply Chain Management report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell and Advanced Therapies Supply Chain Management report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell and Advanced Therapies Supply Chain Management report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports